Ono Pharmaceutical Correlations
| OPHLF Stock | USD 14.91 0.00 0.00% |
The correlation of Ono Pharmaceutical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ono Pharmaceutical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ono Pharmaceutical Co moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Good diversification
The correlation between Ono Pharmaceutical Co and NYA is -0.01 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Ono Pharmaceutical Co and NYA in the same portfolio, assuming nothing else is changed.
Ono |
The ability to find closely correlated positions to Ono Pharmaceutical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ono Pharmaceutical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ono Pharmaceutical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ono Pharmaceutical Co to buy it.
Moving together with Ono Pink Sheet
| 0.61 | JNJ | Johnson Johnson Aggressive Push | PairCorr |
| 0.85 | VFSWW | VinFast Auto | PairCorr |
| 0.79 | VFS | VinFast Auto Buyout Trend | PairCorr |
| 0.78 | TLK | Telkom Indonesia Tbk | PairCorr |
Moving against Ono Pink Sheet
Related Correlations Analysis
| -0.05 | 0.51 | -0.06 | 0.35 | SNY | ||
| -0.05 | -0.58 | 0.63 | 0.06 | BMY | ||
| 0.51 | -0.58 | -0.74 | -0.1 | AZN | ||
| -0.06 | 0.63 | -0.74 | 0.52 | GILD | ||
| 0.35 | 0.06 | -0.1 | 0.52 | NVS | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Ono Pink Sheet performing well and Ono Pharmaceutical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Ono Pharmaceutical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| SNY | 0.95 | 0.01 | (0.04) | 0.08 | 0.98 | 2.03 | 7.04 | |||
| BMY | 1.06 | (0.19) | 0.00 | (0.15) | 0.00 | 2.09 | 11.54 | |||
| AZN | 0.96 | 0.22 | 0.12 | 2.89 | 1.03 | 2.65 | 7.48 | |||
| GILD | 0.84 | (0.30) | 0.00 | (0.40) | 0.00 | 1.32 | 5.55 | |||
| NVS | 0.78 | (0.05) | 0.00 | (0.54) | 0.00 | 1.93 | 4.31 |
Ono Pharmaceutical Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ono Pharmaceutical pink sheet to make a market-neutral strategy. Peer analysis of Ono Pharmaceutical could also be used in its relative valuation, which is a method of valuing Ono Pharmaceutical by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Ono Pharmaceutical Corporate Directors
Ono Pharmaceutical corporate directors refer to members of an Ono Pharmaceutical board of directors. The board of directors generally takes responsibility for the Ono Pharmaceutical's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Ono Pharmaceutical's board members must vote for the resolution. The Ono Pharmaceutical board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Hiromu Habashita | Executive Officer, Chief Director of Research | Profile | |
| Katsuji Teranishi | Head of Marketing Strategy Planning, Deputy Director of Sales and Marketingl and Corporate Officer | Profile | |
| Toshihiro Tsujinaka | Executive Officer, Senior Director of Oncology in Main Sales Unit | Profile | |
| Hiroshi Ichikawa | Sr. Director of Metropolitan Area Management and Metropolitan Area First Branch and Corporate Officer | Profile |
Already Invested in Ono Pharmaceutical Co?
The danger of trading Ono Pharmaceutical Co is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Ono Pharmaceutical is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Ono Pharmaceutical. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Ono Pharmaceutical is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Complementary Tools for Ono Pink Sheet analysis
When running Ono Pharmaceutical's price analysis, check to measure Ono Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ono Pharmaceutical is operating at the current time. Most of Ono Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Ono Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ono Pharmaceutical's price. Additionally, you may evaluate how the addition of Ono Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |